”No Time to Die“ is also having an explosive opening overseas ahead of its U.S. release next weekend
Sony and box office analysts had cautious projections for “Venom: Let There Be Carnage,” and the Marvel film has devoured them with $37.2 million grossed on opening day, including premium format grosses and $11 million in Thursday previews. It is now estimated by Sony for a $71 million opening weekend.
Even without grading the film on a COVID-19 curve, that’s a very solid result for the sequel considering that the original “Venom” earned an $80 million opening on 2018. Reception for “Venom 2,” which leans harder into the dark but silly humor of the symbiote antihero and his hapless human host Eddie, has been stronger than for the original film with a 59% critics score on Rotten Tomatoes and an 86% audience score.
While not as high as the openings for “F9” or “Shang-Chi and the Legend of the Ten Rings,” “Venom 2” is giving hope to theaters that October will provide a dramatic step forward in the rebuilding effort for the post-shutdown box office as a loaded release slate is coinciding with declining COVID-19 infection rates.
This also provides hope for MGM, which will release “No Time to Die” next weekend in the U.S. after what is shaping up to be a post-shutdown record opening overseas. Released in the UK by MGM and 53 other international markets by Universal, the film is currently estimated for a $112.9 million global launch. That would beat pre-release projections of $80-100 million and comes without the aid of China, which gets the Bond film on October 29.
More to come…
Source: Read Full Article